Conditions Treated


Conditions Treated for CAR-T

Currently available CAR-T treatment in our hospital including CD19, CD 22, CD19+CD22,BCMA-targeted CAR-T cell for different conditions.  


The following diseases are most commonly benefit from CAR-T therapy:

B-cell acute lymphoblastic leukemia (B-ALL)

Disease status:

• Refractory/Relapse


CAR-T type:

• CD 19

• CD 22

• CD 19+CD22


B-cell lymphoma

Disease status:

• Refractory/Relapse


CAR-T type:

• CD 19

• CD 22

• CD 19+CD22


Multiple myeloma (MM)

Disease status:

• Refractory/Relapse


CAR-T type:

• BCMA



Stay in Touch
©2017 Lu Daopei hospital-22 Tongji South Rd, Yizhuang Ecomonic and Technological Development Zone, Daxing District, Beijing, China. All rights reserved.
冀ICP备18002416号-1